86 related articles for article (PubMed ID: 15678863)
1. Morphological and immunohistochemical features of tumor infiltrating lymphocytes (TIL) in carcinomas. Note I.
Ardeleanu C; Hălălău F; Benea L; Butur G; Nicolau N; Nicolaescu E; Stăniceanu F; Zurac S
Rom J Morphol Embryol; 1998; 44(1-4):191-9. PubMed ID: 15678863
[TBL] [Abstract][Full Text] [Related]
2. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M; Melichar B; Sedláková I; Steiner I
Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
[TBL] [Abstract][Full Text] [Related]
4. The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.
Houston AM; Michael-Robinson JM; Walsh MD; Cummings MC; Ryan AE; Lincoln D; Pandeya N; Jass JR; Radford-Smith GL; O'Connell J
Hum Pathol; 2008 Feb; 39(2):243-50. PubMed ID: 17961631
[TBL] [Abstract][Full Text] [Related]
5. Quantifying tumour-infiltrating lymphocyte subsets: a practical immuno-histochemical method.
Loughlin PM; Cooke TG; George WD; Gray AJ; Stott DI; Going JJ
J Immunol Methods; 2007 Apr; 321(1-2):32-40. PubMed ID: 17324439
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.
Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN
Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms.
Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A
Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739
[TBL] [Abstract][Full Text] [Related]
8. Functional down-regulation of beta1 and beta2 integrins of lamina propria lymphocytes (LPL) and tumor-infiltrating lymphocytes (TIL) in colorectal cancer patients.
Kitayama J; Tuno N; Nakayama H; Shibata Y; Muto T; Nagawa H
Ann Surg Oncol; 1999; 6(5):500-6. PubMed ID: 10458690
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
10. The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.
Curtis NJ; Primrose JN; Thomas GJ; Mirnezami AH; Ottensmeier CH
Eur J Surg Oncol; 2012 Oct; 38(10):889-96. PubMed ID: 22721580
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of chronic inflammation in a rare case of endobronchial carcinoma.
Gannon PO; Turcotte S; Laporte JL; Saad F; Lapointe R; Duranceau A
Cancer Immunol Immunother; 2010 Sep; 59(9):1411-6. PubMed ID: 20490490
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Importance of CD20
Edin S; Kaprio T; Hagström J; Larsson P; Mustonen H; Böckelman C; Strigård K; Gunnarsson U; Haglund C; Palmqvist R
Sci Rep; 2019 Dec; 9(1):19997. PubMed ID: 31882709
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
14. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
[TBL] [Abstract][Full Text] [Related]
15. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis: a key effector mechanism of lymphocyte action in human nonseminomatous testicular carcinoma?
Schmelz HU; Port M; Hauck EW; Schwerer MJ; Weidner W; Sparwasser C; Abend M
BJU Int; 2005 Jul; 96(1):158-63. PubMed ID: 15963141
[TBL] [Abstract][Full Text] [Related]
17. Primary lung adenocarcinoma with massive lymphocyte infiltration.
Tsuta K; Ishii G; Kim E; Shiono S; Nishiwaki Y; Endoh Y; Kodama T; Nagai K; Nagai K
Am J Clin Pathol; 2005 Apr; 123(4):547-52. PubMed ID: 15743751
[TBL] [Abstract][Full Text] [Related]
18. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
19. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?
van den Engel NK; Winter H; Rüttinger D; Shau I; Schiller M; Mayer B; Moudgil T; Meimarakis G; Stolte M; Jauch KW; Fox BA; Hatz RA
Clin Immunol; 2006 Sep; 120(3):285-96. PubMed ID: 16765089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
